Home > News > Dr. Shelly Gunn Joins CombiMatrix Molecular Diagnostics
July 24th, 2006
Dr. Shelly Gunn Joins CombiMatrix Molecular Diagnostics
Abstract: Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG) announced today that Dr. Shelly Gunn, M.D., Ph.D., has joined CombiMatrix Molecular Diagnostics (CMDX) as its Medical Director.
Source:businesswire
Bookmark:
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013